Technical Analysis for HZNP - Horizon Pharma, Inc.

Grade Last Price % Change Price Change
grade A 31.37 -1.51% -0.48
HZNP closed down 1.51 percent on Friday, April 3, 2020, on 2.2 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Up
Historical HZNP trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.51%
200 DMA Support Bullish -1.51%
Multiple of Ten Bullish Other -1.51%
Wide Bands Range Expansion -1.51%
Overbought Stochastic Strength -1.51%
Up 3 Days in a Row Strength -1.51%
Up 4 Days in a Row Strength -1.51%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Horizon Pharma, Inc., a specialty pharmaceutical company, through its subsidiaries, develops and commercializes medicines for the treatment of arthritis, pain, and inflammatory diseases. The company offers DUEXIS, a proprietary tablet formulation for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis, and to decrease the risk of developing upper gastrointestinal ulcers in patients who are taking ibuprofen for these indications. It also provides LODOTRA/RAYOS, a proprietary delayed-release formulation of low-dose prednisone for the treatment of moderate to severe active rheumatoid arthritis in adults when accompanied by morning stiffness, as well as approved for the treatment of polymyalgia rheumatica, psoriatic arthritis, ankylosing spondylitis, asthma, chronic obstructive pulmonary disease, and other conditions. The company was founded in 2005 and is headquartered in Deerfield, Illinois.
Medicine Health Pharmaceutical Pain Autoimmune Diseases Rheumatoid Arthritis Osteoarthritis Asthma Inflammatory Diseases Arthritis Chronic Obstructive Pulmonary Disease Rheumatology

Is HZNP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 39.1
52 Week Low 22.69
Average Volume 1,709,916
200-Day Moving Average 29.84
50-Day Moving Average 32.63
20-Day Moving Average 28.47
10-Day Moving Average 28.82
Average True Range 2.18
ADX 26.59
+DI 21.77
-DI 22.24
Chandelier Exit (Long, 3 ATRs ) 30.36
Chandelier Exit (Short, 3 ATRs ) 30.34
Upper Bollinger Band 33.10
Lower Bollinger Band 23.84
Percent B (%b) 0.81
BandWidth 32.53
MACD Line -0.69
MACD Signal Line -1.45
MACD Histogram 0.7634
Fundamentals Value
Market Cap 5.12 Billion
Num Shares 163 Million
EPS -2.70
Price-to-Earnings (P/E) Ratio -11.62
Price-to-Sales 2.16
Price-to-Book 2.16
PEG Ratio 0.99
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 33.86
Resistance 3 (R3) 33.88 33.08 33.45
Resistance 2 (R2) 33.08 32.44 33.07 33.31
Resistance 1 (R1) 32.22 32.05 31.82 32.20 33.17
Pivot Point 31.42 31.42 31.22 31.41 31.42
Support 1 (S1) 30.56 30.78 30.16 30.54 29.57
Support 2 (S2) 29.76 30.39 29.75 29.43
Support 3 (S3) 28.90 29.76 29.30
Support 4 (S4) 28.88